This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

New Research Shows Survival Benefit With Daily Dialysis In A Nursing Home Setting

LAS VEGAS, April 24, 2014 /PRNewswire/ -- On Wednesday, April 23, 2014, Affiliated Dialysis Centers, LLC ("ADC") shared the release of clinical data in a Late Breaking Poster Session at the 2014 National Kidney Foundation (NKF) Spring Clinical Meetings in Las Vegas, NV. Xelay Acumen, a strategy and medical data analytics firm, independently led the data collection and analysis effort, and Dr. Alex Yang, M.D. presented the results. Earlier this year, ADC presented the first results of a large epidemiological health outcomes clinical research study involving End Stage Renal Disease (ESRD) patients who received their dialysis care on-site in the nursing home setting. The study utilized the largest known database of ESRD patients receiving dialysis in the nursing home setting, consisting of nearly 4,000 patients tracked over a 6-year follow-up period. In this new study utilizing this clinical database, health status and patient outcomes were compared in nursing home patients receiving daily home hemodialysis vs. conventional thrice weekly hemodialysis.

Patients with ESRD on dialysis have one of the highest mortality rates of any disease, surpassing many cancers. Within this ESRD patient population, nursing home patients typically have even greater health challenges by virtue of their need to be in a nursing home. Thus identifying beneficial treatment paradigms for these patients is a significant clinical priority.

The key findings from this large epidemiological research study were that, compared to conventional thrice weekly dialysis, patients treated on-site in a nursing home setting with daily home hemodialysis had:

  1. Generally improved health status
  2. Lower monthly mortality rates
  3. Significantly longer median survival (50 months vs 30 months; P<0.001) 

"The ADC database is a unique and extremely important research tool, which allows us to study a large population of ESRD patients on dialysis in the nursing home setting and test hypotheses about optimal care and outcomes for this at-risk patient population," said Dr. Yang.  "The improvements in health status, and particularly in overall survival, in patients treated with daily home dialysis in this study are provocative and suggest the need for a prospective outcomes study."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs